Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 199, pseudogene (RN7SL199P) is a non-coding RNA and classified as a pseudogene of the 7SL RNA family[1][6]. Pseudogenes like RN7SL199P are typically derived from functional genes—in this case, from the canonical 7SL RNA, which is an essential component of the signal recognition particle (SRP), a ribonucleoprotein complex that mediates the cotranslational insertion of secretory proteins into the endoplasmic reticulum[1][5]. Unlike the functional RN7SL1 gene, RN7SL199P does not produce a functional product and has no direct, characterized biological or pathophysiological role; it is not recognized as a receptor, enzyme, drug target, or therapeutic target[1][6]. Although some pseudogenes are known to play roles in RNA-mediated gene regulation, there are no data specifically implicating RN7SL199P in such mechanisms[4]. The broader 7SL RNA pseudogene family is thought to contribute to genome evolution and sequence diversity, but direct functions for RN7SL199P are not established[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 199, pseudogene (RN7SL199P).